Anavo Therapeutics BV

Over Anavo Therapeutics BV

Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades.

We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavo is developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications.

Anavo is backed by blue-chip investors M Ventures, INKEF Capital, Taiho Ventures, and Bioqube Ventures.

Trefwoorden

• Drug Discovery
• Oncology
• Phospatase Biology

Adres

• Hoofdkantoor

  J.H. Oortweg 192333CH LeidenZuid-Holland, Nederland

Team per functiegebied

Gebaseerd op 2 openbare functieprofielen, stand van 4 september 2026.

• Executive / C-Suite2